| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |